Combination according to claim 1 in which the pharmaceutically acceptable salt is selected from the group consisting of chloride, bromide, orotate, aspartate, acid aspartate, citrate, acid citrate, magnesium citrate, phosphate, acid phosphate, fumarate, acid fumarate, magnesium fumarate, glycerophosphate, lactate, maleate and acid maleate, mucate, oxalate, acid oxalate, pamoate, acid pamoate, sulphate, acid sulphate, glucose phosphate, tartrate, acid tartrate, magnesium tartrate, 2-amino ethanesulphonate, magnesium 2-amino ethanesulphonate, methanesulphonate, choline tartrate, tricloroacetate, and trifluoroacetate
GlyHisLysCu(II) Peptide Sequence : GlyHisLys(Cu) Chemical Formula : CHNOCu (GHKCu complex) Molecular Weight : 401.91 g/mol CAS Number : 49557-75-7 Purity : Typically supplied at 99% purity as determined by HPLC
Genetic variants in B12 metabolism pathways (e.g., MTHFR, MTR, MTRR genes) can influence how efficiently your body processes and utilizes B12, potentially affecting both side-effect risk and clinical benefit
They can also help stave off diseases that may put your health at risk
Like Hashimotos disease, its considered an autoimmune condition